Time Is Key: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma
Current Oncology · 04.06.2026 · 33 (6) · 333
DOI: 10.3390/curroncol33060333 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, online erschienen am 04.06.2026. Verfasst von Asli Altunbas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Heart Failure and Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Lymphoproliferative Disorders, Lymphoma, Large B-Cell, Diffuse, Heart Transplantation. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post-transplant lymphoproliferative disorder (PTLD) involving the central nervous system (CNS) is a rare but serious life-threatening complication seen in recipients of solid organ transplant. Primary CNS encompasses 5–15% of all types of PTLD diagnoses, and heart transplant recipients represent 3–5% of those reported cases. Diagnosis is often delayed due to the highly variable presentation, with some cases remaining undiagnosed for years. Multidisciplinary collaboration is crucial for early diagnosis and management. A 53-year-old woman patient presented with altered mental status. MRI revealed nodular ventriculitis and bilateral periventricular hyperdense infiltrates. CSF studies demonstrated lymphocytic pleocytosis, elevated protein, and EBV-PCR-positive results. A stereotactic brain needle biopsy confirmed the presence of EBV-positive diffuse large B-cell lymphoma, consistent with primary CNS PTLD, 14 months after her heart transplant. Despite appropriate management, the patient experienced progressive neurological decline and ultimately suffered a fatal intracerebral hemorrhage. We demonstrate the importance of the early diagnosis and variable presentation of post-heart-transplant PTLD. The importance of surveillance regardless of EBV status and close monitoring of disease progression due to potential life-threatening complications, such as fatal hemorrhages. Therefore, primary CNS-PTLD remains a challenging disease and is being increasingly recognized with improved transplant recipient survival and prolonged exposure to chronic immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Heart Failure and Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA.
- Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL 32224, USA.
- Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
- Division of Infectious Diseases, Mayo Clinic, Jacksonville, FL 32224, USA.
- Division of Hematology, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Asli Altunbas, Aarti Desai, Hussien Al Asi, Laxmi Raj Bangari, Juan Leoni, Harry Powers, Rohan Goswami
Zitieren
APA
Altunbas, A., Desai, A., Muniz, A., Al Asi, H., Chaudhary, R., Bangari, L. R., Dadwal, S., Ruiz, J., Leoni, J., Hammack, J., Powers, H., Foran, J., & Goswami, R. (2026). Time Is Key: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma. Current Oncology, 33(6), 333. https://doi.org/10.3390/curroncol33060333
Vancouver
Altunbas A, Desai A, Muniz A, Al Asi H, Chaudhary R, Bangari LR, et al. Time Is Key: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma. Current Oncology. 2026;33(6):333. doi:10.3390/curroncol33060333
BibTeX
@article{Altunbas2026,
author = {Altunbas, Asli and Desai, Aarti and Muniz, Andrea and Al Asi, Hussien and Chaudhary, Rajvi and Bangari, Laxmi Raj and Dadwal, Surbhi and Ruiz, Jose and Leoni, Juan and Hammack, Julie and Powers, Harry and Foran, James and Goswami, Rohan},
title = {Time Is Key: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {6},
pages = {333},
doi = {10.3390/curroncol33060333}
}
EUVIMED